Ashrafi M - Search Results

1

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

Khodaie-Ardakani MR, Mirshafiee O, Farokhnia M, Tajdini M, Hosseini SM, Modabbernia A, Rezaei F, Salehi B, Yekehtaz H, Ashrafi M, Tabrizi M, Akhondzadeh S. Khodaie-Ardakani MR, et al. Among authors: ashrafi m. Psychiatry Res. 2014 Mar 30;215(3):540-6. doi: 10.1016/j.psychres.2013.12.051. Epub 2014 Jan 9. Psychiatry Res. 2014. PMID: 24480077 Clinical Trial.

2

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Abbasi SH, et al. Among authors: ashrafi m. J Affect Disord. 2012 Dec 10;141(2-3):308-14. doi: 10.1016/j.jad.2012.03.033. Epub 2012 Apr 18. J Affect Disord. 2012. PMID: 22516310 Clinical Trial.

3

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

Sepanjnia K, Modabbernia A, Ashrafi M, Modabbernia MJ, Akhondzadeh S. Sepanjnia K, et al. Among authors: ashrafi m. Neuropsychopharmacology. 2012 Aug;37(9):2093-100. doi: 10.1038/npp.2012.58. Epub 2012 May 2. Neuropsychopharmacology. 2012. PMID: 22549115 Free PMC article. Clinical Trial.

4

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S. Asadabadi M, et al. Among authors: ashrafi m. Psychopharmacology (Berl). 2013 Jan;225(1):51-9. doi: 10.1007/s00213-012-2796-8. Epub 2012 Jul 11. Psychopharmacology (Berl). 2013. PMID: 22782459 Clinical Trial.

5

Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.

Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, Yadegari N, Akhondzadeh S. Jafarinia M, et al. Among authors: ashrafi m. Hum Psychopharmacol. 2012 Jul;27(4):411-8. doi: 10.1002/hup.2242. Hum Psychopharmacol. 2012. PMID: 22806822 Clinical Trial.

6

Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

Askari N, Moin M, Sanati M, Tajdini M, Hosseini SM, Modabbernia A, Najand B, Salimi S, Tabrizi M, Ashrafi M, Hajiaghaee R, Akhondzadeh S. Askari N, et al. Among authors: ashrafi m. CNS Drugs. 2012 Oct 1;26(10):883-92. doi: 10.2165/11635850-000000000-00000. CNS Drugs. 2012. PMID: 22873680 Clinical Trial.

7

Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.

Ghaleiha A, Entezari N, Modabbernia A, Najand B, Askari N, Tabrizi M, Ashrafi M, Hajiaghaee R, Akhondzadeh S. Ghaleiha A, et al. Among authors: ashrafi m. J Psychiatr Res. 2013 Feb;47(2):175-80. doi: 10.1016/j.jpsychires.2012.09.015. Epub 2012 Oct 9. J Psychiatr Res. 2013. PMID: 23063327 Clinical Trial.

8

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

Khajavi D, Farokhnia M, Modabbernia A, Ashrafi M, Abbasi SH, Tabrizi M, Akhondzadeh S. Khajavi D, et al. Among authors: ashrafi m. J Clin Psychiatry. 2012 Nov;73(11):1428-33. doi: 10.4088/JCP.12m07706. Epub 2012 Oct 16. J Clin Psychiatry. 2012. PMID: 23146150 Clinical Trial.

9

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.

Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M, Hosseini SM, Tajdini M, Ghaleiha A, Akhondzadeh S. Modabbernia A, et al. Among authors: ashrafi m. CNS Drugs. 2013 Jan;27(1):57-65. doi: 10.1007/s40263-012-0022-1. CNS Drugs. 2013. PMID: 23233269 Clinical Trial.

10

Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

Khodaie-Ardakani MR, Seddighi S, Modabbernia A, Rezaei F, Salehi B, Ashrafi M, Shams-Alizadeh N, Mohammad-Karimi M, Esfandiari GR, Hajiaghaee R, Akhondzadeh S. Khodaie-Ardakani MR, et al. Among authors: ashrafi m. J Psychiatr Res. 2013 Apr;47(4):472-8. doi: 10.1016/j.jpsychires.2013.01.011. Epub 2013 Jan 30. J Psychiatr Res. 2013. PMID: 23375406 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters